Author:
AL Azzam Khaldun M.,Saad Bahruddin,Adnan Rohana,Idiris Saleh Muhammad
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Cass QB, Galatti TF (2008) A method for determination of the plasma levels of modafinil enantiomers, (±)−modafinic acid and modafinil sulphone by direct human plasma injection and bidimensional achiral-chiral chromatography. J Pharm Biomed Anal 46:937–944
2. Mitchell HA, Bogenpohl JW, Liles LC, Epstein MP, Bozyczko-Coyne D, Williams M, Weinshenker D (2008) Behavioral responses of dopamine β-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action. Pharmacol Biochem Behav 91:217–222
3. Prisinzano T, Podobinski J, Tidgewell K, Luo M, Swenson D (2004) Synthesis and determination of the absolute configuration of the enantiomers of modafinil. Tetrahedron Asymmetr 15:1053–1058
4. Wong YN, King SP, Simcoe D, Gorman S, Laughton W, McCormick GC, Grebow P (1999) Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects. J Clin Pharmacol 39:281–288
5. Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebleq G, Arora S, Black J (2006) Effect of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: A 12-week, multicenter, double-blind, randomized, placebo-controlled study in Ncpap-adherent adults. Clin Ther 28:689–706